Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000116260 | SCV000317035 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Center for Pediatric Genomic Medicine, |
RCV000431747 | SCV000511644 | likely benign | not provided | 2017-01-02 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Athena Diagnostics | RCV000116260 | SCV000612298 | benign | not specified | 2021-03-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000530637 | SCV000653907 | benign | Congenital myasthenic syndrome 8 | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000116260 | SCV000714924 | benign | not specified | 2018-01-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Breakthrough Genomics, |
RCV000431747 | SCV005256410 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000116260 | SCV000150178 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. |